Disseminated tumour cells: Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas

Virchows Archiv

Volumn 439, Issue 2, 2001, Pages 109-117

  Vogel, Ilka ^a   Kalthoff, Holger ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Disseminated tumour cells; Gastrointestinal carcinoma; Immunocytochemical detection; Molecular detection; Pancreatic carcinoma; Prognosis

Indexed keywords

CANCER STAGING; CANCER SURVIVAL; DISSEMINATED CANCER; EARLY DIAGNOSIS; GASTROINTESTINAL CARCINOMA; HUMAN; HUMAN CELL; METASTASIS; PANCREAS CARCINOMA; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; TUMOR CELL;

ASCITES; BONE MARROW; COLORECTAL NEOPLASMS; DNA, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM CIRCULATING CELLS; PANCREATIC NEOPLASMS; PERITONEAL LAVAGE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034879468     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280100476     Document Type: Review

References (79)

1. Urokinase plasminogen activator receptor (uPA-R): One potential characteristic of metastatic phenotypes in minimal residual disease
2. Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcriptase-polymerase chain reaction assay
3. Immunocytochemical detection of isolated epithelial cells in bone marrow: Non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase
4. Tumorzelldissemination in das Knochenmark und in die Peritonealhöhle
5. Expression of MUC-1 epitopes on normal bone marrow: Implications for the detection of micrometastatic tumour cells
6. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction
7. Improved methods using the reverse transcriptase-polymerase chain reaction to detect tumour cells
8. In vitro detection of occult bone marrow metastases in patients with colorectal cancer hepatic metastases
9. Monoclonal cytokeratin antibodies that distinguish simple from stratified squamous epithelia: Characterization on human tissue
10. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients
11. Human lymphoid cells express epithelial membrane antigen. Implications for diagnosis of human neoplasms
12. Perioperative quantitative analysis of cytokeratin 20 mRNA in peripheral venous blood of patients with colorectal adenocarcinoma
13. Comparative analyses of bone marrow micrometastases in breast and gastric cancer
14. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin
15. Molecular detection of micrometastases and circulating tumor cells in solid tumors
16. Pittfalls in the detection of disseminated non-hematological tumor cells
17. Detection of micrometastases in colerectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction
18. Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease
19. Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease
20. Individual development and uPA-receptor expression of disseminated tumor cells in bone marrow: A reference to early systemic disease in solid cancer
21. Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer
22. Classification of isolated tumor cells and micrometastasis
23. Prognostic significance of bone marrow micrometastases in patients with gastric cancer
24. The molecular detection of circulating tumor cells
25. Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction
26. Immunocytological detection of micrometastatic cells: Comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients
27. Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro
28. Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes
29. Biological behaviour and clinical implications on micrometastases
30. Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: A quality-assurance initiative of the EORTC Melanoma Cooperative Group
31. Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma
32. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells
33. Sensitivity of assays designed for the detection of disseminated epithelial tumor cells is influenced by cell separation methods
34. Avoiding false positives with PCR
35. Cytokeratin-positive cells in bone marrow in comparison with other prognostic factors in colon carcinoma
36. Micrometastases and survival in stage II colorectal cancer
37. Prognostic significance of micrometastatic tumor cells in bone marrow of colorectal cancer patients
38. Molecular cytogenetic analysis of cytokeratin 20-labeled cells in primary tumors and bone marrow aspirates from colorectal carcinoma patients
39. Duct changes and K-ras mutations in the disease free pancreas: Analysis of type, age relation and spatial distribution
40. Immunotherapy for colorectal cancer
41. A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow
42. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies
43. Detection of genetic alterations in micometastatic cells in bone marrow of cancer patients by fluorescence in situ hybridization
44. Low frequency epithelial cells in marrow aspirates from prostate cancer patients are cytogenetically aberrant
45. Increased sensitivity for detection of micrometastatases in bone marrow/peripheral blood stem-cell products from breast-cancer patients by negative immunomagnetic separation
46. Diagnosis of micrometastases by the amplification of tissue-specific genes
47. Does the use of immunohistochemistry to identify micrometastases provide useful information in the staging of node-negative non-small cell lung carcinomas?
48. A new approach to phenotyping disseminated tumor cells: Methodological advances and clinical implications
49. Detection of ras gene mutations in perioperative peripheral blood with pancreatic adenocarcinoma
50. Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells
51. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow
52. Early metastasis of human solid tumors: Expression of cell adhesion molecules
53. Detection and clinical importance of micrometastatic disease
54. Bedeutung der regionalen lymphatischen tumorzelldisseminierung bei patienten mit resektablem nicht-kleinzelligem bronchialcarcinom
55. Molecular and immunological detection of circulating tumor cells and micrometastases from solid rumors
56. CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging
57. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: Establishment of working models for human micrometastases
58. Utilization of polymerase chain reaction technology in the detection of solid tumors
59. Micrometastases in bone marrow: Prognostic indicators for pancreatic cancer
60. Micrometastatic cells in bone marrow: In vitro detection with anitcytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies
61. Epithelial tumor cells in bone marrow of patients with colorectal cancer: Immunocytochemical detection, phenotypic characterization, and prognostic significance
62. Micrometastatic tumor cells in bone marrow of patients with gastric cancer: Methodological aspects of detection and prognostic significance
63. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19
64. Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker
65. The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease
66. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR
67. Detection of cancer metastasis in regional lymph nodes: Comparative histological and inmunohistological investigations with the broad-range anticytokeratin monoclonal antibody A45-B B3
68. Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma
69. Epithelial tumor cells in bone marrow of patients with pancreatic carcinoma detected by immunocytochemical staining
70. Detection of micrometastasis in bone marrow of pancreatic cancer patients
71. Keratine gene expression in non-epithelial tissues. Detection with polymerase chain reaction
72. Active specific immunotherapy for stage II and stage III human colon cancer: A randomised trial
73. Disseminated tumor cells in pancreatic cancer patients detected by immunocytology: A new prognostic factor
74. Multivariate analysis reveals RT-PCR-detected tumour cells in the blood and/or bone marrow of patients with colorectal carcinoma as an independent prognostic factor
75. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription assays and multiple blood samples
76. Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20
77. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection
78. Limitations of reverse transcriptase-polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow